Drug Testing Locations - New Cumberland, PA

Drug Testing in New Cumberland, PA

New Cumberland, Pennsylvania Statistics

In 2022, New Cumberland, located in Cumberland County, reported a 12% increase in drug-related arrests compared to the previous year.

Cumberland County saw a 5% decrease in prescription opioid abuse in New Cumberland from 2021 to 2022.

The New Cumberland police department reported 85 drug overdose incidents in 2021.

A study in 2022 found that 15% of high school students in Cumberland County, including New Cumberland, had experimented with illegal drugs.

In New Cumberland, Cumberland County, 22% of homeless individuals reported drug addiction as a primary concern in 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in New Cumberland, PA & Drug Testing Policies

Employers in New Cumberland, PA, are increasingly adopting drug testing policies to ensure a safe and productive work environment. These policies often require pre-employment screening and random testing, especially for positions of higher responsibility or involving safety-sensitive tasks.

Many employers align their policies with the guidelines enforced by state organizations like the Pennsylvania Department of Labor & Industry, ensuring compliance with labor laws while promoting a drug-free workplace. Programs focus on education and rehabilitation to support employees struggling with addiction.

Government Efforts with Drug Problems in New Cumberland, PA

The government of New Cumberland, PA, has implemented various strategies to combat drug abuse in the community. Efforts include collaboration with local law enforcement, outreach programs, and educational initiatives aimed at prevention and awareness. Key local entities such as the Cumberland County Bureau of Drug and Alcohol Services coordinate resources to address this challenge.

The state government supports these local efforts with support from initiatives like the Pennsylvania's Opioid Disaster Declaration to tackle opioid misuse. These initiatives focus on improving access to treatment, reducing stigma, and promoting recovery programs throughout the state, including New Cumberland.

Local Drug Busts & News in New Cumberland, PA

In New Cumberland, PA, recent drug busts have highlighted the ongoing challenges faced by local law enforcement in tackling narcotics distribution. The community has expressed concern over the increasing presence of illicit substances, urging for more concerted efforts between police departments and community organizations. Collaborative initiatives are being developed to address the root causes and prevent future incidents.

One notable drug-related event in New Cumberland involved a collaborative operation between borough police and neighboring towns, resulting in the apprehension of several suspects. The operation was hailed as a success, with authorities seizing significant quantities of narcotics. These efforts not only disrupt the supply chain but also serve as a stern warning to those involved in drug trafficking activities.

Community outreach programs have become integral in New Cumberland's approach to dealing with drug issues. Police and local organizations host educational workshops aimed at raising awareness about the dangers of drug abuse. These workshops are designed to empower residents, particularly the youth, to make informed decisions and to discourage involvement in drug-related activities.

As New Cumberland continues to face drug-related challenges, the local government has prioritized funding for rehabilitation and support services. Increased access to these resources is helping those struggling with addiction to find paths to recovery. By focusing on both prevention and rehabilitation, the community aims to cultivate a safer and healthier environment for all residents.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in New Cumberland, PA. Trusted by employers nationwide for accurate results and exceptional service.

Pennsylvania DOT/Non DOT Physicals

Pennsylvania Vision Tests

Pennsylvania Audiograms

Pennsylvania Respirator Fit Tests

Pennsylvania Lift Tests

Pennsylvania Background Checks

Clinical Testing Services

TB Testing in PA

Diabetes Testing in PA

Infectious Disease Testing in PA

Sickle Cell Anemia Testing in PA

Women/Men's Health Testing in PA

Resources & Citations

Cumberland County Bureau of Drug and Alcohol Services

Pennsylvania Department of Drug and Alcohol Programs

Pennsylvania Department of Health - o-drugs

PA House of Representatives - Drug Crisis

Partnership to End Addiction

Substance Abuse and Mental Health Services Administration (SAMHSA)

Narcotics Anonymous

Alcoholics Anonymous

Drug Testing Near New Cumberland, PA

Shiremanstown, PA

Penbrook, PA

Bressler, PA

Bressler-Enhaut-Oberlin, PA

West Fairview, PA

Enhaut, PA

Harrisburg, PA

Dauphin, PA

Paxtang, PA

Wormleysburg, PA

Steelton, PA

New Market, PA

Camp Hill, PA

Lower Allen, PA

Lemoyne, PA

Frequently Asked Questions

Customer Reviews